PpSC developing Topical Platelet-rich plasma Kit (TPRPK) in order to facilitate the further development, adoption and implement. of PRP for Healthcare with initial specialisation on cell rejuvenation: TPRPK

Programme(s)
H2020-EU.3. - PRIORITY 'Societal challenges
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s): EIC-SMEInst-2018-2020 - SME instrument

Call for proposal: H2020-SMEInst-2018-2020-1

Funding Scheme: SME-1 - SME instrument phase 1

Grant agreement ID: 827957

Objective
PpSC and its forthcoming product: Platelet-rich plasma Kit® (TPRPK) is being developed to exploit the massive potential for painless & cost efficient procedures available to patients with various skin conditions and global Facial rejuvenation sector. The key innovations with TPRPK platform are increased lifespan of platelet-rich plasma and none invasive topical application instead of multiple painful injections. In addi-tion, the IP protected PRP storage device and how one feeds into the other. PpSC will initially focus on healing and rejuvenation of the injured tissues along with a calculation of resources reductions achieved through the process. It is envisaged that the PpSC will scale its TPRPK operations across healthcare and cosmetic sectors worldwide in due course.